Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab.

Source:http://linkedlifedata.com/resource/pubmed/id/19179465

Blood 2009 Apr 23 113 17 4094-100

Download in:

View as

General Info

PMID
19179465